Item request has been placed!
×
Item request cannot be made.
×
Processing Request
MAPK-ERK Pathway.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Park JI;Park JI
- Source:
International journal of molecular sciences [Int J Mol Sci] 2023 Jun 02; Vol. 24 (11). Date of Electronic Publication: 2023 Jun 02.
- Publication Type:
Editorial
- Language:
English
- Additional Information
- Source:
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE
- Publication Information:
Original Publication: Basel, Switzerland : MDPI, [2000-
- Subject Terms:
- Abstract:
The name extracellular signal-regulated kinase (ERK) was first used for a cell cycle regulating Ser/Thr protein kinase cloned in mammalian cells [...].
- References:
Int J Mol Sci. 2020 Jul 30;21(15):. (PMID: 32751750)
Int J Mol Sci. 2019 Jul 12;20(14):. (PMID: 31336840)
Int J Mol Sci. 2019 Feb 15;20(4):. (PMID: 30781441)
Int J Mol Sci. 2020 Jul 24;21(15):. (PMID: 32722178)
Proc Natl Acad Sci U S A. 1989 Sep;86(18):6940-3. (PMID: 2550926)
Int J Mol Sci. 2019 Aug 25;20(17):. (PMID: 31450703)
Int J Mol Sci. 2020 Jun 05;21(11):. (PMID: 32516969)
Int J Mol Sci. 2019 Jan 22;20(3):. (PMID: 30678221)
Int J Mol Sci. 2020 Sep 01;21(17):. (PMID: 32882982)
Int J Mol Sci. 2019 Jun 13;20(12):. (PMID: 31200510)
Science. 1990 Jul 6;249(4964):64-7. (PMID: 2164259)
Int J Mol Sci. 2020 Jun 23;21(12):. (PMID: 32586047)
Int J Mol Sci. 2019 Sep 26;20(19):. (PMID: 31561471)
- Grant Information:
R01 CA138441 United States CA NCI NIH HHS; CA138441 United States CA NCI NIH HHS
- Accession Number:
EC 2.7.11.24 (Extracellular Signal-Regulated MAP Kinases)
- Publication Date:
Date Created: 20230610 Date Completed: 20230612 Latest Revision: 20231018
- Publication Date:
20240829
- Accession Number:
PMC10253477
- Accession Number:
10.3390/ijms24119666
- Accession Number:
37298618
No Comments.